Home
Categories
EXPLORE
Music
Society & Culture
True Crime
Comedy
Religion & Spirituality
Business
Arts
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8e/c7/36/8ec73660-f6e6-e562-8093-227ed688be9b/mza_11911370317690733547.jpg/600x600bb.jpg
Retina Synthesis
Retina Synthesis
158 episodes
1 week ago
We discuss with Dr. Rajesh C. Rao, Leonard Miller Professor of Ophthalmology, Kellogg Eye Center, University of Michigan, the results of a Phase I trial exploring the use of stem cells injected subretinally in eyes with geographic atrophy. The results are promising.
Show more...
Education
RSS
All content for Retina Synthesis is the property of Retina Synthesis and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We discuss with Dr. Rajesh C. Rao, Leonard Miller Professor of Ophthalmology, Kellogg Eye Center, University of Michigan, the results of a Phase I trial exploring the use of stem cells injected subretinally in eyes with geographic atrophy. The results are promising.
Show more...
Education
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8e/c7/36/8ec73660-f6e6-e562-8093-227ed688be9b/mza_11911370317690733547.jpg/600x600bb.jpg
The Good Days Dilemma - Support for Patient Co-Payments in Retinal Pharmacotherapy
Retina Synthesis
12 minutes
3 months ago
The Good Days Dilemma - Support for Patient Co-Payments in Retinal Pharmacotherapy
We discuss the current state of the Good Days charitable foundation with Dr. Michael Lai, MD. PhD, Retina Group of Washington, Assistant Clinical Professor, Georgetown University School of Medicine
Retina Synthesis
We discuss with Dr. Rajesh C. Rao, Leonard Miller Professor of Ophthalmology, Kellogg Eye Center, University of Michigan, the results of a Phase I trial exploring the use of stem cells injected subretinally in eyes with geographic atrophy. The results are promising.